B. Braun Melsungen AG has finally acquired Intermedt Medizin & Technik GmbH which is allowing the company to complete its extensive portfolio as a systems provider for extracorporeal blood treatment (dialysis).
Asahi Kasei Corporation has obtained the approval for manufacturing and selling Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg in Japan for the treatment of the fungal infections of aspergillosis, mucormycosis, and cryptococcosis.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?